or Try an Advanced Search...

    Technical Analysis for NTBL - Notable Labs, Ltd.

    Grade Last Price % Change Price Change
    F 0.17 -8.11% -0.02
    NTBL closed down 8.11 percent on Friday, November 1, 2024, on 3 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NTBL trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -8.11%
    Older End-of-Day Signals for NTBL ...

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NTBL Chart by TradingView
    Basic chart:

    Profile

    Notable Labs, Ltd. Description

    Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Treatment Acute Myeloid Leukemia Orphan Drug Protein Kinase Inhibitor Myelodysplastic Syndrome Chronic Myeloid Leukemia Kinase 1 Lintuzumab

    Is NTBL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Aug 29 Notable Labs to Present Data on September 4th at SOHO 2024
    Jul 24 Notable Labs receives FDA clearance to proceed with Volasertib phase 2 study
    Jul 24 Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study
    Jun 20 Notable Labs files to sell 19.74M ordinary shares, pre-funded warrants
    May 9 Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
    See more NTBL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.24
    52 Week Low 0.16
    Average Volume 3,256,385
    200-Day Moving Average 0.90
    50-Day Moving Average 0.45
    20-Day Moving Average 0.35
    10-Day Moving Average 0.29
    Average True Range 0.07
    RSI (14) 30.07
    ADX 22.74
    +DI 33.01
    -DI 29.13
    Chandelier Exit (Long, 3 ATRs) 0.45
    Chandelier Exit (Short, 3 ATRs) 0.38
    Upper Bollinger Bands 0.51
    Lower Bollinger Band 0.19
    Percent B (%b) -0.06
    BandWidth 91.42
    MACD Line -0.06
    MACD Signal Line -0.05
    MACD Histogram -0.0152
    Fundamentals Value
    Market Cap 1.53 Million
    Num Shares 9 Million
    EPS -1.61
    Price-to-Earnings (P/E) Ratio -0.11
    Price-to-Sales 90.01
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.22
    Resistance 3 (R3) 0.22 0.20 0.21
    Resistance 2 (R2) 0.20 0.19 0.20 0.21
    Resistance 1 (R1) 0.19 0.19 0.19 0.19 0.20
    Pivot Point 0.17 0.17 0.17 0.17 0.17
    Support 1 (S1) 0.16 0.16 0.15 0.15 0.14
    Support 2 (S2) 0.14 0.15 0.14 0.13
    Support 3 (S3) 0.13 0.14 0.13
    Support 4 (S4) 0.12